Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Shaman patents new antifungal agents

Jan. 21, 1997

Abbott isolates fusacandin antifungal agents

Jan. 20, 1997

Tularik, Merck & Co. extend R&D agreement

Jan. 17, 1997

Takeda discloses lankacidin derivatives

Jan. 17, 1997

Generic version of Monistat-7 approved by FDA

Jan. 16, 1997

New approvals for Zagam

Jan. 16, 1997

Biochemie reports new cephalosporins

Jan. 16, 1997

Abbott discloses antibacterial tiacumicin derivatives

Jan. 16, 1997

New antibiotics from BTG

Jan. 16, 1997

3DP and ViroPharma establish drug discovery collaboration

Jan. 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...